SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-17-000043
Filing Date
2017-02-07
Accepted
2017-02-07 17:03:05
Documents
40
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR PERIOD ENDED DECEMBER 31, 2016 bivi-20161231_10q.htm 10-Q 262027
2 EXHIBIT 31.1 bivi-20161231_10qex31z1.htm EX-31.1 12106
3 EXHIBIT 32.1 bivi-20161231_10qex32z1.htm EX-32.1 5799
  Complete submission text file 0001520138-17-000043.txt   1481924

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE bivi-20161231.xml EX-101.INS 246334
5 XBRL CALCULATION FILE bivi-20161231_cal.xml EX-101.CAL 17042
6 XBRL DEFINITION FILE bivi-20161231_def.xml EX-101.DEF 24925
7 XBRL LABEL FILE bivi-20161231_lab.xml EX-101.LAB 130839
8 XBRL PRESENTATION FILE bivi-20161231_pre.xml EX-101.PRE 95600
9 XBRL SCHEMA FILE bivi-20161231.xsd EX-101.SCH 16451
Mailing Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915
Business Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915 312-283-5793
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-55292 | Film No.: 17579904
SIC: 2834 Pharmaceutical Preparations